Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT03931876
A Single Ascending Dose Study of AV-006 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 24, 2019
Completion: Nov 1, 2019